ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2021

Early Histopathological Changes of the Salivary Glands Associated with the Development of Primary Sjögren’s Syndrome

Xiaomei Shan1, Clara Reichardt1, Jeeshan Singh1, Anne Zeitler2, Christine Schauer1, Jasmin Knopf1, Martin Herrmann1, Gerhard Grossmayer1, Georg Schett1 and Luis Munoz1, 1Universitätsklinikum Erlangen, Erlangen, Germany, 2Friedrich-Alexander University Erlangen Nürnberg, Erlangen, Germany

Meeting: ACR Convergence 2022

Keywords: Autoantibody(ies), autoimmune diseases, Mouse Models, Other, neutrophils, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Sjögren's Syndrome – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Primary Sjögren’s syndrome (PSS) is a chronic inflammatory disease affecting exocrine glands including salivary and lacrimal glands that leads to dry eyes and mouth along with various systemic manifestations. While in established disease, systemic adaptive immune system activation is a key process in PSS and autoantibodies against nuclear proteins (Ro, La) are formed, the initiating events that target the exocrine glands in PSS are yet to be identified. A glandular epithelial deregulation is thought to be the critical initiator of PSS pathogenesis. In the steady state, innate immune cells patrolling salivary glands are under the influence of the autonomic system and readily react after sensing damage of the tissue. The goal of this work is to evaluate the early epithelial changes induced by the stimulation of salivary secretion under the action of specific beta-adrenergic agonists.

Methods: We employed a mouse model of sialadenitis provoked by the induction of an abrupt secretion of hypercalcemic saliva in mice treated with calcium gluconate (300µmol/Kg) followed by one dose of the β1-adrenergic agonist denopamine (14µmol/Kg) or the β2 agonist fenoterol (1.4 mg/Kg) after 30 minutes. Repeated salivary secretion stimulation for 3 weeks caused early histopatological changes suggestive of a sialadenitis confirmed by image mass cytometry (IMC) of submandibular glands (SMG). Evaluation of sera for autoantibodies and salivary and lacrimal tissues by IMC after a recovery phase of 8 weeks revealed an association of salivary epithelial damage and autoimmunity against Ro and La autoantigens.

Results: Beta adrenergic stimulation of hypercalcemic mice caused cellular swelling (increased cellular size) and an absolute loss of epithelial nuclei of the mucous acini of SMG of mice that persisted until the end of the recovery phase. The multiplexed IMC analysis revealed a strong downregulation of TGF-ß in the mucous acini accompanied with the upregulation of the ribosomal protein S6 along with an early accumulation of CD20 positive B-cells. After the recovery phase, the mice with ß-adrenergic stimulation displayed a significant reduction of tear production and developed autoantibodies against Ro, La and the N-terminus peptide of the M3 muscarinic receptor.

Conclusion: The ribosomal protein S6 is part of the translation machinery and is activated by phosphorylation via the mammalian target of rapamycin (mTOR) pathway and TGF-ß is a potent inhibitor of the mTOR pathway. We conclude that subtle damage of salivary epithelial cells concur in the activation of the mTOR pathway which is involved in the regulation of cell size, growth, proliferation and autophagy. These early changes in the mucous acini are sufficient to initiate B-cell infiltration and autoantibody response conditioning the appearance of Sjögren´s Syndrome-like manifestations in our murine model.


Disclosures: X. Shan, None; C. Reichardt, None; J. Singh, None; A. Zeitler, None; C. Schauer, None; J. Knopf, None; M. Herrmann, None; G. Grossmayer, None; G. Schett, None; L. Munoz, None.

To cite this abstract in AMA style:

Shan X, Reichardt C, Singh J, Zeitler A, Schauer C, Knopf J, Herrmann M, Grossmayer G, Schett G, Munoz L. Early Histopathological Changes of the Salivary Glands Associated with the Development of Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/early-histopathological-changes-of-the-salivary-glands-associated-with-the-development-of-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-histopathological-changes-of-the-salivary-glands-associated-with-the-development-of-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology